Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;23(4):e13645.
doi: 10.1111/tid.13645. Epub 2021 Jun 13.

A eulogy for Dr Francisco Miguel Marty Forero

Sophia Koo  1   2   3 , Tyler D Bold  4 , Matthew Pellan Cheng  5 , Dimitrios Farmakiotis  6 , Joshua A Hill  7   8 , Bettina Knoll  9 , Yiannis Koullias  10 , Alyssa R Letourneau  3   11 , Jessica Little  1   2   3   11 , Elizabeth A Moulton  12 , Zoe Freeman Weiss  1   2   3   11 , Sarah P Hammond  2   3   11
Affiliations

A eulogy for Dr Francisco Miguel Marty Forero

Sophia Koo et al. Transpl Infect Dis. 2021 Aug.

Abstract

As some of those who were lucky enough to have been mentored by Dr Francisco Marty in transplant infectious diseases, we stand with the larger medical community in mourning his untimely death and in commemorating him as a uniquely exceptional and talented physician, investigator, teacher, mentor, friend, artist, and human being.

Keywords: CMV; COVID-19; HHV-6; brincidofovir; composite tissue transplantation; humanism in medicine; influenza; invasive aspergillosis; isavuconazole; letermovir; maribavir; mentorship; mucormycosis; transplant infectious diseases; “don't cover discover”.

PubMed Disclaimer

References

REFERENCES

    1. Marty FM, Lowry CM, Rodriguez M, et al. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. Clin Infect Dis. 2005;41(1):e5-e8. https://doi.org/10.1086/430827
    1. Marty FM, Ljungman P, Papanicolaou GA, et al. Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial. Lancet Infect Dis. 2011;11(4):284-292. https://doi.org/10.1016/S1473-3099(11)70024-X
    1. Papanicolaou GA, Silveira FP, Langston AA, et al. Maribavir for refractory or resistant cytomegalovirus infections in hematopoietic-cell or solid-organ transplant recipients: a randomized, dose-ranging, double-blind, phase 2 study. Clin Infect Dis. 2019;68(8):1255-1264. https://doi.org/10.1093/cid/ciy706
    1. Marty FM, Winston DJ, Rowley SD, et al. CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. N Engl J Med. 2013;369(13):1227-1236. https://doi.org/10.1056/NEJMoa1303688
    1. Marty FM, Ljungman P, Chemaly RF, et al. Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation. N Engl J Med. 2017;377(25):2433-2444. https://doi.org/10.1056/nejmoa1706640

LinkOut - more resources